Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-16 @ 7:59 AM
Study NCT ID:
NCT07171827
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2025-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
Sponsor:
Organization: